19 Jul 2021
Digital polymerase chain reaction which is also known as digital PCR or dPCR is refinement technique with the help of biotechnology of conventional polymerase chain reaction procedures that can be applied to directly quantify and clonally amplify nucleic acids strands containing DNA, cDNA, or RNA. The key dissimilarity between dPCR and traditional PCR lies in the process of measuring nucleic acids amounts, where dPCR being a more precise method than PCR, even if error can be more in the hands of inexperienced users. A "digital" measurement system quantitatively and discretely measures a certain number of variables, whereas an “analog” measurement generates certain measurements based on already measured patterns. PCR carries out one reaction per single sample and dPCR also carries out a single reaction within a sample, but the sample is separated into a large number of partitions and the reaction is done in each partition individually. This separation enables a more reliable collection and sensitive measurement of nucleic acid amounts. The method is useful for studying variations in gene sequences such as copy number variants and point mutations and it has routine application used for clonal amplification of samples for next-generation sequencing.
"Global Digital PCR Market is valued at USD 428.7 Million in 2019 and expected to reach USD 1312.3 Million by 2025 with the CAGR of 17.33% over the forecast period."
Growing prevalence of chronic diseases is one of the major factors expected to drive the Global Digital PCR Market.
Bio-Rad Laboratories, Inc. is an American developer and manufacturer established in 1952 and headquartered at 1000 Alfred Nobel Dr, Hercules, California, 94547, United States. Specialties in Laboratory instruments, apparatus, and consumables for life science research, products used to separate, purify, identify, analyze, and amplify biological materials, and laboratory diagnostics products to support monitoring and treatment of diseases. Bio-Rad Laboratories, Inc had nearly 8,000 Employees and had revenue of $2 Billion.
Thermo Fisher Scientific is an American Company established in 2006 and headquartered at Waltham, Massachusetts, 02451, United States. Specialties in Analytical Instruments, Laboratory Supply Chain Programs and eCommerce, Laboratory Equipment, Lab Services, Specialty Diagnostics, Life Sciences, Pharma Services, and CDMO. Thermo Fisher Scientific Inc had nearly 80,000 employees and had revenue of $32 Billion.
JN Medsys established in 2010 and headquartered at Singapore, Central Singapore. Specialties in digital PCR, genomic tools, diagnostic tools, biotechnology, diagnostics, manufacturing, and development. JN Medsys had nearly 28 Employees and had revenue of $5 Million.
RainDance Technologies established in 2004 and headquartered at Lexington, Massachusetts, United States. Specialties in Targeted Sequencing, DNA Sequencing, Biotechnology, Digital PCR, and Cancer Research.
Stilla Technologies is a leading global biotechnology company established in 2013 and headquartered at Mail du Professeur Georges Mathé, Villejuif, Ile-de-France. Specialties in genetic testing, Crystal Digital PCR™ technology, dPCR and more. Stilla Technologies had nearly 65 Employees and had revenue of $14 Million.
Key Benefits for Global Digital PCR Market Report–
Global Digital PCR Market report covers in depth historical and forecast analysis.
Global Digital PCR Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Digital PCR Market report helps to identify opportunities in market place.
Global Digital PCR Market report covers extensive analysis of emerging trends and competitive landscape.